TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16087956

Group type: EXPERIMENTAL
Intervention: Sequential chemoradiotherapy (induction CT with cisplatin 120 mg/m2 on days 1, 29, and 57; vinorelbine 30 mg/m2/wk from day 1 to day 78; followed by thoracic RT at 66 Gy in 33 fractions)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (RT started on day 1 with two cycles of cisplatin 20 mg/m2/d and etoposide 50 mg/m2/d; consolidation therapy with cisplatin 80 mg/m2 on days 78 and 106; vinorelbine 30 mg/m2/wk from days 78 to 127)
Number of subjects: 205
Study: 12593422

Group type: EXPERIMENTAL
Intervention: 123I-BMIPP SPECT
Number of subjects: 34

Group type: COMPARATOR
Intervention: 201Tl SPECT
Number of subjects: 34

Group type: COMPARATOR
Intervention: PYP/Tl dual-isotope SPECT
Number of subjects: 34
Study: 10510168

Group type: EXPERIMENTAL
Intervention: morphology and morphometry analysis of the pars opercularis using MRI
Number of subjects: 108
Study: 7577293

Group type: EXPERIMENTAL
Intervention: Nebulized lignocaine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study: 1774421

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: L-deprenyl
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 7054041

Group type: EXPERIMENTAL
Intervention: Golytely
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard prep
Number of subjects: 20
Study: 31106905

Group type: EXPERIMENTAL
Intervention: pH 4 water-in-oil emulsion
Number of subjects: 20

Group type: COMPARATOR
Intervention: pH 5.8 water-in-oil emulsion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: pH 4 water-in-oil emulsion after SDS challenge
Number of subjects: 20
Study: 28765136

Group type: EXPERIMENTAL
Intervention: COPD-web (interactive web page for self-management)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 25854537

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study: 23967189

Group type: EXPERIMENTAL
Intervention: Educational intervention focusing on experimental control and base rate consideration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention before task)
Number of subjects: 0
Study: 21856044

Group type: EXPERIMENTAL
Intervention: Tibial intraosseous access
Number of subjects: 182

Group type: COMPARATOR
Intervention: Humeral intraosseous access
Number of subjects: 182

Group type: COMPARATOR
Intervention: Peripheral intravenous access
Number of subjects: 182
Study: 19910828

Group type: EXPERIMENTAL
Intervention: Repeated exercise condition (5 sets of arm curls using dumbbells at 70% isometric maximal voluntary contraction until failure on days 1, 2, 3, and 5 of recovery)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition (no treatment applied)
Number of subjects: 12
Study: 16492823

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 14

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 14
Study: 15329509

Group type: EXPERIMENTAL
Intervention: Pravastatin (10-20 mg) plus diet
Number of subjects: 8009

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 8009
Study: 11036801

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (DEX)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study: 9283055

Group type: EXPERIMENTAL
Intervention: Estradiol valeranate 10 mg (E)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Estradiol valeranate 4 mg plus prasterone enantate 200 mg (E+P)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 55
Study: 8510192

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (nicotine gum)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 38
Study: 3305207

Group type: COMPARATOR
Intervention: Monthly maintenance chemotherapy for 2 years (Group A)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Monthly maintenance chemotherapy plus viral oncolysate injection on day 15 (Group A+IT)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Maintenance chemotherapy after early consolidation
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Observation only after early consolidation
Number of subjects: 269
Study: 31668996

Group type: EXPERIMENTAL
Intervention: BIPOLIFE® (serious game)
Number of subjects: 41

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 41
Study: 29885752

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 469

Group type: COMPARATOR
Intervention: Conventional oral health education
Number of subjects: 469
Study: 28088925

Group type: EXPERIMENTAL
Intervention: Kundalini yoga (KY) intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Memory enhancement training (MET; gold-standard, active control)
Number of subjects: 81
Study: 25698407

Group type: EXPERIMENTAL
Intervention: Screening arm (21,210 men)
Number of subjects: 42376

Group type: COMPARATOR
Intervention: Control arm (21,166 men)
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 42376

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 42376
Study: 23650800

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) intervention applied to bilateral Xuehai (SP 10), Zusanli (ST36), Taichong (LR3), and Sanyinjiao (SP 6) for 30 min, once daily for 15 days.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intensive endurance exercise (Harvard step test) for 30 min, once daily for 15 days.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 30
Study: 21091250

Group type: EXPERIMENTAL
Intervention: Lactotripeptides (3 mg of Ile‐Pro‐Pro/Val‐Pro‐Pro)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lactotripeptides
Number of subjects: 55
Study: 18209670

Group type: EXPERIMENTAL
Intervention: OTZ (oxothiazolidine‐4‐carboxylic acid) 210 mg/kg per day every 8 hrs for 14 days
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: OTZ (oxothiazolidine‐4‐carboxylic acid)
Number of subjects: 215
Study: 16599263

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 x 5 g daily for 6 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15128893

Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin (100 mg/m² IV on days 1, 22, and 43) plus radiotherapy (60 to 66 Gy in 30 to 33 fractions over 6 to 6.6 weeks)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Radiotherapy alone (60 to 66 Gy in 30 to 33 fractions over 6 to 6.6 weeks)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Concurrent cisplatin plus radiotherapy
Number of subjects: 459

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 459
Study: 11844177

Group type: EXPERIMENTAL
Intervention: Infoson (air-filled albumin microspheres)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hysterosalpingography (Iopamiron 370)
Number of subjects: 23
Study: 9566993

Group type: EXPERIMENTAL
Intervention: Food cooked in iron pots
Number of subjects: 45

Group type: COMPARATOR
Intervention: Food cooked in aluminum pots
Number of subjects: 45
Study: 8065733

Group type: EXPERIMENTAL
Intervention: Intraligamentary injection of slow-release methylprednisolone (Depomedrol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active placebo (Mepivacaine)
Number of subjects: 0
Study: 3418088

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA) enemas (2 g in 100 ml)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 5-aminosalicylic acid (5-ASA) suppositories (1 g b.i.d.)
Number of subjects: 39
Study: 31743564

Group type: EXPERIMENTAL
Intervention: TTC web-based self-management program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no access to TTC program)
Number of subjects: 42
Study: 30316496

Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE) prior to Cognitive Bias Modification for Interpretation (CBM-I)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Relaxation prior to Cognitive Bias Modification for Interpretation (CBM-I)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Neutral Thinking prior to Cognitive Bias Modification for Interpretation (CBM-I)
Number of subjects: 111
Study: 28557376

Group type: EXPERIMENTAL
Intervention: Tapered implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cylindrical implants
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both tapered and cylindrical implants
Number of subjects: 40
Study: 24433518

Group type: EXPERIMENTAL
Intervention: Mindful Transition to Parenthood Program (4-week duration)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 33
Study: 23283675

Group type: EXPERIMENTAL
Intervention: Tibial tubercle osteotomy (TTO)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Quadriceps snip (QS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 22088886

Group type: EXPERIMENTAL
Intervention: Male neonates
Number of subjects: 131

Group type: COMPARATOR
Intervention: Female neonates
Number of subjects: 131
Study: 18665689

Group type: EXPERIMENTAL
Intervention: Parent Management Training‐‐The Oregon Model (PMTO)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Regular services comparison group
Number of subjects: 112
Study: 16448992

Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sustained smoking (sustained smokers)
Number of subjects: 240
Study: 12595499

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 7674

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7674
Study: 11432177

Group type: EXPERIMENTAL
Intervention: Anterior technique of inferior alveolar nerve block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional technique of inferior alveolar nerve block
Number of subjects: 100
Study: 9438598

Group type: EXPERIMENTAL
Intervention: 40-Gy radiotherapy and 4 weeks 5-FU treatment
Number of subjects: 218

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 218
Study: 7512469

Group type: EXPERIMENTAL
Intervention: Verapamil SR 240mg daily
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Enalapril 20mg daily
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Combination therapy (Verapamil + Enalapril or Hydrochlorothiazide)
Number of subjects: 931

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 931
Study: 3520382

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO) - 20 consecutive daily treatments of 100% O2 followed by 7 booster treatments over 6 months
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group - received 'air' (12.5% O2 at 1.75 atmospheres absolute)
Number of subjects: 82
Study: 29568976

Group type: EXPERIMENTAL
Intervention: Intranasal naloxone 0.8 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intramuscular naloxone 0.8 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Heat pain threshold
Number of subjects: 12
Study: 27879642

Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus curcumin and Boswellia serrata (curcumin/BSE group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Mediterranean diet alone (MD group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Comparison between curcumin/BSE group and MD group
Number of subjects: 47
Study: 24270165

Group type: EXPERIMENTAL
Intervention: Interval training (5 trials/day over 3 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Massed training (15 trials in 1 session)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 21756847

Group type: EXPERIMENTAL
Intervention: PegIFNα2a 180 μg/wk plus daily Rbv 800-1200 mg
Number of subjects: 431

Group type: COMPARATOR
Intervention: PegIFNα2b 1.5 μg/kg/week plus daily Rbv 800-1200 mg
Number of subjects: 431
Study: 20735515

Group type: EXPERIMENTAL
Intervention: SRP plus 500 mg of azithromycin per day (3 days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: SRP plus placebo
Number of subjects: 29
Study: 19014165

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Beta-tricalcium phosphate
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Beta-tricalcium phosphate composite graft (with 10% to 20% autogenous bone)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Autogenous bone
Number of subjects: 48
Study: 15851525

Group type: EXPERIMENTAL
Intervention: Rituximab monotherapy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Rituximab plus cyclophosphamide (R+CTX)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Rituximab plus methotrexate (R+MTX)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Methotrexate alone (MTX)
Number of subjects: 161
Study: 12830040

Group type: EXPERIMENTAL
Intervention: Terminal warm blood cardioplegia
Number of subjects: 103

Group type: COMPARATOR
Intervention: Intermittent hyperkalemic cold blood cardioplegia and topical cardiac cooling (Control)
Number of subjects: 103
Study: 10806608

Group type: EXPERIMENTAL
Intervention: tolbutamide 500 mg plus tolcapone 200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: tolbutamide 500 mg plus placebo
Number of subjects: 12
Study: 8660076

Group type: EXPERIMENTAL
Intervention: Plasma calprotectin concentration in cystic fibrosis group
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Chest radiograph Northern score
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Plasma copper
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Plasma gamma‐glutamyltransferase
Number of subjects: 31

Group type: COMPARATOR
Intervention: Traditional indices of inflammation
Number of subjects: 31
Study: 2064999

Group type: EXPERIMENTAL
Intervention: Skicon Hygrometer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CM420a
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CM420b
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CM820
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corneometers (CM420a, CM420b, CM820)
Number of subjects: 0
Study: 6635871

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31971139

Group type: EXPERIMENTAL
Intervention: Training of private health providers and community sensitization on effective prompt care seeking and referral
Number of subjects: 10809
Study: 31553517

Group type: EXPERIMENTAL
Intervention: Stage I hypertension
Number of subjects: 196

Group type: COMPARATOR
Intervention: Prehypertension
Number of subjects: 196
Study: 29504812

Group type: EXPERIMENTAL
Intervention: Dulaglutide single-use pen (SUP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Insulin degludec FlexTouch®
Number of subjects: 48
Study: 26843473

Group type: EXPERIMENTAL
Intervention: Sustained release hGH (SR-hGH) 2-mg injections weekly for 3 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 33
Study: 24014349

Group type: EXPERIMENTAL
Intervention: Violent movie clips
Number of subjects: 209

Group type: COMPARATOR
Intervention: Nonviolent movie clips
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Prior exposure to media violence
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: High levels of real-life violence exposure
Number of subjects: 209
Study: 22344045

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training (30 Hz, ±1‐2 mm, 3 times per week)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL) training (identical training without vibration)
Number of subjects: 24
Study: 21126667

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine (10 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine (10 mg) with morphine (100 mcg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isobaric bupivacaine (10 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isobaric bupivacaine (10 mg) with morphine (100 mcg)
Number of subjects: 100
Study: 17437725

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 533

Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 533
Study: 16281214

Group type: EXPERIMENTAL
Intervention: Brief Eclectic Psychotherapy (BEP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 24
Study: 11955901

Group type: EXPERIMENTAL
Intervention: Healon5 (sodium hyaluronate 2.3%)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Healon (sodium hyaluronate 1%)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Healon GV (sodium hyaluronate 1.4%)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (Healon in 1 eye and Healon GV in the fellow eye)
Number of subjects: 99
Study: 10678478

Group type: EXPERIMENTAL
Intervention: Drama-in-education programme
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Written information about HIV/AIDS
Number of subjects: 1080
Study: 9202548

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Analgesia (PCA) with intravenous alfentanil, mean dose 1.03 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with intravenous pethidine, mean dose 62.5 mg
Number of subjects: 100
Study: 1527232

Group type: EXPERIMENTAL
Intervention: Carbamazepine and valproic acid combination
Number of subjects: 1

Group type: COMPARATOR
Intervention: Carbamazepine alone
Number of subjects: 1

Group type: COMPARATOR
Intervention: Valproic acid alone
Number of subjects: 1
Study: 2862112

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study: 30952505

Group type: EXPERIMENTAL
Intervention: Dried plums (DP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Refined carbohydrate-rich snack (low-fat muffins: LFM)
Number of subjects: 100
Study: 30457892

Group type: EXPERIMENTAL
Intervention: Turmeric-containing herbal combination tablets
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Turmeric tablets
Number of subjects: 30
Study: 27053525

Group type: EXPERIMENTAL
Intervention: Leucine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EAA
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 24989666

Group type: EXPERIMENTAL
Intervention: Delayed-release dimethyl fumarate (DMF) 240 mg BID
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Delayed-release dimethyl fumarate (DMF) 240 mg TID
Number of subjects: 540
Study: 22301554

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 11
Study: 20826249

Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mononuclear cells (BMCs) - 100 million intracoronary BMCs administered 3 to 10 days post-procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17999989

Group type: EXPERIMENTAL
Intervention: PTGS2 polymorphisms (specifically Ex10 +837 T>C marker rs5275) in PLCO cohort
Number of subjects: 2321

Group type: EXPERIMENTAL
Intervention: Haplotype analyses of PTGS2 variants in PLCO cohort
Number of subjects: 2321
Study: 15781538

Group type: EXPERIMENTAL
Intervention: hyperbaric intrathecal solution of 10 mg bupivacaine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: isobaric intrathecal solution of 10 mg bupivacaine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: hypobaric intrathecal solution of 10 mg bupivacaine
Number of subjects: 150
Study: 12552188

Group type: EXPERIMENTAL
Intervention: EDTA-containing propofol (ECP) 2 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sulfite-containing propofol (SCP) 2 mg/kg
Number of subjects: 40
Study: 10817176

Group type: EXPERIMENTAL
Intervention: Colonoscope fitted with a transparent cap
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ordinary colonoscope without a cap
Number of subjects: 50
Study: 8891643

Group type: EXPERIMENTAL
Intervention: gap paradigm
Number of subjects: 23

Group type: COMPARATOR
Intervention: control group (elderly normal subjects)
Number of subjects: 23
Study: 1905707

Group type: EXPERIMENTAL
Intervention: Regimen A (tegafur + MMC)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Regimen B (UFT + MMC)
Number of subjects: 169
Study: 29574438

Group type: EXPERIMENTAL
Intervention: Community mobilisation and advocacy intervention (Sonke CHANGE) implemented over 18 months.
Number of subjects: 2600

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 2600

Group type: EXPERIMENTAL
Intervention: Community mobilisation and advocacy intervention (Sonke CHANGE).
Number of subjects: 2600
Study: 27261987

Group type: EXPERIMENTAL
Intervention: Mindfulness-based yoga intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Walking control condition
Number of subjects: 0
Study: 24074719

Group type: EXPERIMENTAL
Intervention: NexoBrid™ (NXB) applied for 4 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of Care (SOC) including surgical excisional or non-surgical debridement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NexoBrid™ (NXB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: NexoBrid™ (NXB) and SOC
Number of subjects: 0
Study: 22214181

Group type: EXPERIMENTAL
Intervention: Fatigue information condition
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control condition (generic sleep-related information)
Number of subjects: 88
Study: 20464297

Group type: EXPERIMENTAL
Intervention: 70%WPI:30%MS (milk whey proteins and modified starch)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Maltodextrin (control group)
Number of subjects: 16
Study: 18406955

Group type: EXPERIMENTAL
Intervention: Triamcinolone
Number of subjects: 84

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 84
Study: 15620767

Group type: EXPERIMENTAL
Intervention: Extraction
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Successful Coronectomy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Failed Coronectomy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Extraction, Successful Coronectomy, Failed Coronectomy
Number of subjects: 128